Sci Transl Med by Johnson, Tory P. et al.
  
Supplementary Materials for 
 
Nodding syndrome may be an autoimmune reaction to the parasitic 
worm Onchocerca volvulus 
 
Tory P. Johnson, Richa Tyagi, Paul R. Lee, Myoung-Hwa Lee, Kory R. Johnson, 
Jeffrey Kowalak, Abdel Elkahloun, Marie Medynets, Alina Hategan, Joseph Kubofcik, 
James Sejvar, Jeffrey Ratto, Sudhir Bunga, Issa Makumbi, Jane R. Aceng, 
Thomas B. Nutman, Scott F. Dowell, Avindra Nath* 
 
 
*Corresponding author. Email: natha@ninds.nih.gov 
 
Published 15 February 2017, Sci. Transl. Med. 9, eaaf6953 (2017) 
DOI: 10.1126/scitranslmed.aaf6953 
 
This PDF file includes: 
 
Fig. S1. Representative image of immunoprecipitation experiments. 
Fig. S2. Subtyping of leiomodin-1 autoantibodies from patients with nodding 
syndrome. 
Fig. S3. Immunofluorescence of leiomodin-1–transfected cells with sera from 
unaffected village controls. 
Fig. S4. Coimmunofluorescence of human neurons with leiomodin-1 and patient 
CSF. 
Fig. S5. Leiomodin-1 transcripts are expressed in the brain as detected by RNA 
sequencing. 
Table S1. Proteins with enriched autoantibodies in patients with nodding 
syndrome. 
Table S2. Top four proteins with enriched autoantibodies in patients with nodding 
syndrome. 
Table S3. Leiomodin-1 transcripts are expressed in the brain. 
Table S4. Rabbit leiomodin-1 antibodies are neurotoxic. 
Table S5. Antibodies in patient sera are neurotoxic. 
Table S6. Leiomodin-1 antibodies from patients are neurotoxic. 
Table S7. O. volvulus proteins identified by mass spectrometry. 
Table S8. Leiomodin-1 antibodies cross-react with O. volvulus antigens. 
www.sciencetranslationalmedicine.org/cgi/content/full/9/377/eaaf6953/DC1 
  
Fig. S1. Representative image of immunoprecipitation experiments. Immunoprecipitation of 
leiomodin-1 IVTT product (input) by rabbit anti-leiomodin-1, sera from a patient with Nodding 





Fig. S2. Subtyping of leiomodin-1 autoantibodies from patients with nodding syndrome. 
Antibodies to leiomodin-1 from patients with NS are IgG and IgM as determined by 






Fig. S3. Immunofluorescence of leiomodin-1–transfected cells with sera from unaffected 
village controls. Unaffected village control (UVC) sera co-immunostained with leiomodin-1 
(red) on leiomodin-1 transfected cells show limited reactivity to rare cells (UVC) and no co-















Fig. S4. Coimmunofluorescence of human neurons with leiomodin-1 and patient CSF. (A) 
Human neuronal cultures were fixed with paraformaldehyde, permeabilized with acetone and 
then immunostained with rabbit polyclonal leiomodin-1 antibody (red) and human CSF from two 
patients with NS (#4 and #5) (green) or sera from a patient with NS (#14) as a positive control 
(green). Colocalization of rabbit anti-leiomodin-1 antibodies with antibodies in the CSF or serum 
in the cytoplasm and neurites was observed. (B) Higher magnification images of patient #5 
demonstrate co-localization of CSF from patient with NS and rabbit polyclonal leimodin-1 
antibody in the neuronal cytoplasm (arrow). Secondary antibody controls in A and B show 











Fig. S5. Leiomodin-1 transcripts are expressed in the brain as detected by RNA sequencing. 
Illumina Body Map 2.0 publically available RNAseq data demonstrated the presence of 
leiomodin-1 transcripts in the brain. www.illumina.com/science/data_library.ilmn  Data 
downloaded 7 July, 2013 (37). 
 
  
Table S1. Proteins with enriched autoantibodies in patients with nodding syndrome. 
 
ID Ingenuity Gene Annotation Fold change disease versus control 
BC080187.1 LMOD1 32649.50 
NM_007262.1 PARK7 753.14 
BC057779.1 COX4I2 652.93 
BC098117.1 C7orf10 155.43 
BC004242.1 HNRNPUL1 6.77 
NM_001002755.1 NFU1 5.48 
NM_024821.1 CCDC134 4.98 
NM_002824.4 PTMS 4.51 
BC018732.1 CYB5R1 4.37 
BC007957.1 DDRGK1 4.29 
NM_001024631.1 ATXN3 4.11 
NM_001011700.1 MCCD1 3.82 
BC070290.1 TRDN 3.82 
BC007872.1 TK1 3.80 
BC028725.2 ELMOD1 3.75 
NM_012249.2 RHOQ 3.55 
NM_022465.2 IKZF4 3.53 
BC057774.1 TRMT10B 3.51 
BC010741.1 TRIT1 3.50 
BC000809.1 TCEAL1 3.44 
NM_007173.3 PRSS23 3.33 
BC018206.1 MZT2A 3.26 
BC017492.1 COG8 3.25 
NM_020064.2 BARHL1 3.14 
BC093700.1 PIN4 3.10 
BC025278.1 AIG1 3.10 
BC012183.1 UBQLNL 3.08 
NM_033277.1 LACRT 3.08 
BC058288.1 CCDC40 3.08 
NM_012086.1 GTF3C3 3.08 
BC008374.1 SH3YL1 3.07 
BC017236.1 CSNK1G1 2.97 
BC075800.1 PRKAR2B 2.95 
BC053660.1 PNPT1 2.94 
NM_004231.2 ATP6V1F 2.92 
BC013039.1 GADD45GIP1 2.92 
NM_145268.1 C7orf45 2.85 
BC073866.1 PRMT6 2.83 
NM_138353.1 DCAF15 2.81 
BC051688.1 PNMAL1 2.78 
BC042035.1 MGC72080 2.75 
NM_006258.1 PRKG1 2.73 
NM_021244.2 RRAGD 2.71 
BC048217.1 SPATA5 2.71 
BC012266.2 ATG12 2.71 
BC011906.1 ISCU 2.70 
BC014051.1 AIMP1 2.67 
NM_002697.2 POU2F1 2.66 
NM_183383.1 RNF13 2.66 
NM_003146.2 SSRP1 2.66 
NM_198287.1 ING4 2.66 
NM_133640.3 MED22 2.66 
NM_007041.2 ATE1 2.60 
NM_000071.1 CBS 2.60 
BC030237.1 SLC22A18AS 2.58 
BC040339.1 NOD1 2.55 
BC036450.1 SAMHD1 2.54 
NM_012129.1 CLDN12 2.51 
BC034483.1 HSPA1L 2.49 
NM_206853.1 QKI 2.47 
NM_000403.3 GALE 2.46 
BC014225.2 HOPX 2.46 
NM_000318.1 PEX2 2.45 
BC025263.1 CDCA4 2.43 
NM_024548.2 CEP97 2.40 
BC009614.1 SPAG16 2.37 
BC025930.1 NPLOC4 2.37 
NM_152260.1 RPUSD2 2.36 
BC004407.1 C9orf64 2.36 
NM_153007.3 ODF4 2.35 
BC051843.1 MAP4 2.34 
BC013737.1 HDAC6 2.33 
NM_012110.1 CHIC2 2.32 
NM_152613.1 WBP2NL 2.31 
BC008819.1 NR1H3 2.31 
BC006148.1 OVOL2 2.29 
BC004902.1 KIAA0947 2.27 
BC014095.2 RELA 2.26 
BC056872.1 NCOA5 2.25 
NM_052820.1 CORO2A 2.25 
BC032422.1 KIR2DL3 (includes others) 2.23 
NM_152261.1 C12orf23 2.22 
BC055427.1 TNIK 2.22 
BC028954.1 PGBD3 2.22 
NM_007019.1 UBE2C 2.21 
BC002555.1 CLK3 2.19 
NM_033064.1 ATCAY 2.19 
NM_006454.2 MXD4 2.19 
NM_005902.1 SMAD3 2.19 
BC050456.1 THBS4 2.17 
NM_022170.1 EIF4H 2.15 
NM_015991.1 C1QA 2.15 
BC008892.1 ALDH3A1 2.14 
NM_080414.1 VPS16 2.14 
NM_017563.1 IL17RD 2.13 
NM_005207.1 CRKL 2.13 
NM_002143.2 HPCA 2.12 
BC065041.1 PLB1 2.12 
NM_144602.1 C16orf78 2.12 
BC017376.2 RNF31 2.11 
BC028206.1 KIR3DL1 2.11 
NM_201403.1 MOB3C 2.11 
NM_058217.1 RAD51C 2.11 
BC024187.2 DHX40 2.10 
BC035055.1 GABRA4 2.09 
NM_007066.3 PKIG 2.09 
NM_174896.2 C1orf162 2.09 
NM_174889.2 NDUFAF2 2.08 
BC007206.1 SHD 2.08 
NM_138612.1 HAS3 2.07 
NM_016052.1 RRP15 2.07 
NM_014042.1 ANAPC15 2.06 
BC022189.2 C17orf47 2.06 
BC002758.1 ADAT1 2.06 
BC020630.1 CAMK2N1 2.06 
NM_002823.2 PTMA 2.05 
BC004885.1 TMEM234 2.05 
NM_003732.1 EIF4EBP3 2.05 
NM_152876.1 FAS 2.05 
NM_017952.2 PTCD3 2.04 
NM_138430.3 ADPRHL1 2.04 
BC032124.1 BRD3 2.04 
NM_006998.3 SCGN 2.03 
NM_006244.1 PPP2R5B 2.03 
BC019015.2 MED29 2.03 
NM_014380.1 NGFRAP1 2.02 
BC015358.1 HTATIP2 2.02 
NM_000810.2 GABRA5 2.02 
NM_153236.2 GIMAP7 2.02 
BC002704.1 STAT1 2.01 
NM_032955.1 AIF1 2.01 
BC095406.1 H2AFY 2.00 
BC009230.2 PAGE5 2.00 
BC016821.1 MBIP 2.00 
NM_017971.1 MRPL20 2.00 
NM_003085.2 SNCB 2.00 
NM_001003937.1 TSPYL6 2.00 
 
  
Table S2. Top four proteins with enriched autoantibodies in patients with nodding 
syndrome. 
 
Gene ID Protein name Function Fold Change  
LMOD1   Leiomodin 1 Actin capping 32649.50  
PARK7 DJ1 Oxidative stress response 753.14  
COX4I2 
Cytochrome C oxidase subunit 
4 
Terminal enzyme of the 
mitochondrial ETC 652.93  
C7orf10 
CaiB/baiF CoA-transferase 
family protein C7orf10 
Unknown, possible 







Table S3. Leiomodin-1 transcripts are expressed in the brain. Data shown are the leiomodin-
1 copy number normalized to GAPDH copy number from three independent replicates from 
figure 2E. 
 
Sample Hela NSC Neuron Brain 1 Brain 2 Muscle 
Replicate 1 7.83E-20 1.13E-19 3.43E-20 2.67E-19 3.68E-20 8.86E-24 
Replicate 2 9.17E-08 2.3E-07 3.11E-07 3.51E-06 2.89E-05 0.000115 








Table 4. Rabbit leiomodin-1 antibodies are neurotoxic. Differences in viability of neurons 
treated with rabbit anti-leiomodin-1, normal rabbit sera or saponin. Data shown are percent 
viability from cells from Fig 3A. 
 
Well # Rabbit anti-leiomodin-1 Normal rabbit sera Saponin 
1 62.28 30.39 32.28 
2 72.61 34.91 37.13 
3 66.94 32.72 35.56 
4 60.32 32.05 34.23 
5 59.77 31.85 33.34 
6 90.23 52.34 50.94 
7 87.56 52.70 51.18 
8 83.39 48.01 46.87 
9 78.88 46.59 46.28 







Table S5. Antibodies in patient sera are neurotoxic. Differences in viability of neurons treated 
with either sera or antibody depleted sera from a single patient with NS.  Data shown are percent 
viability from cells from Fig 3B. 
 
Well # Patient sera #1 Antibody depleted patient sera 
1 12.93 64.57 
2 15.03 67.93 
3 15.12 74.39 
4 15.19 90.7 










Table S6. Leiomodin-1 antibodies from patients are neurotoxic. Differences in toxicity of 
patient sera or patient sera selectively depleted of leiomodin-1 auto-antibodies. Data shown are 
percent toxicity from cells from Fig 3C. 
 
Patient ID # Sera Leiomodin-1 antibody depleted sera 
1 68.87 45.68 
4 79.1 54.33 
10 32.54 17.95 





Table S7. O. volvulus proteins identified by mass spectrometry. 
 
Accession number Entry name Protein name 
P30162 ACT1_ONCVO Actin-1 
J0DN48 J0DN48_LOALO Glyceraldehyde-3-phosphate dehydrogenase 
P46434 GST1_ONCVO Glutathione S-transferase 1 
O18532 O18532_ONCVO 22 upper 
O44941 O44941_ONCVO Peroxidoxin-2 
O16006 O16006_DIRIM Peroxidoxin-1 
O46147 O46147_ONCVO Putative heparan sulfate 
O96906 O96906_ONCVO Aspartic protease 
Q25597 Q25597_ONCVO Beta-galactoside-binding lectin 
Q7YZX3 Q7YZX3_ONCVO Enolase 
A8PFE3 A8PFE3_BRUMA Enolase, putative 
Q95W51 Q95W51_ONCVO Prolyl-4-hydroxylase alpha subunit-like protein 
Q9U9R9 Q9U9R9_ONCVO Fructose-bisphosphatealdolase 
Q25632 TPM_ONCVO Tropomyosin 
P11503 HSP70_ONCVO Heat shock 70 kDa protein 
Q26357 Q26357_ONCVO Heat shock 70 kDa protein 
P27541 HSP70_BRUMA Heat shock 70 kDa protein 
J9FG14 J9FG14_WUCBA Heat shock 70 protein 
H2B652 H2B652_9MAXI Heat shock protein 70 
Q0RAH1 Q0RAH1_ONCVE 60 kDachaperonin 
P29691 EF2_CAEEL Elongation factor 2 
A8PJV1 A8PJV1_BRUMA Translation elongation factor aEF-2, putative 
Q54NB6 FKBP4_DICDI FK506-binding protein 4 
A8QHE7 A8QHE7_BRUMA 
FKBP-type peptidyl-prolylcis-trans isomerase-59, 
BmFKBP59 
A8P3D2 A8P3D2_BRUMA 
Glycosyl hydrolase family 20, catalytic domain 
containing protein 
A8PGN9 A8PGN9_BRUMA Glycosyl hydrolases family 18 protein 
A8NGD6 A8NGD6_BRUMA Phosphoglycerate kinase 
F1L2P3 F1L2P3_ASCSU Phosphoglycerate kinase 
A8QGN5 A8QGN5_BRUMA TPR Domain 
A0B5P0 SYR_METTP Arginine--tRNA ligase 
A9H9A8 ATPB_GLUDA ATP synthase subunit beta 
E1FVE7 E1FVE7_LOALO Branched-chain-amino-acid aminotransferase 
G0P5J3 G0P5J3_CAEBE CBN-EGL-30 protein 
B8FUN4 DNAK_DESHD Chaperone protein DnaK 
E1FT93 E1FT93_LOALO Intermediate filament protein B 
Q1NJR3 Q1NJR3_9DELT Mannosyl-glycoprotein endo-beta-N-
acetylglucosamidase 
J9EH08 J9EH08_WUCBA MFP2 family protein 
J9EW18 J9EW18_WUCBA Phosphoenolpyruvatecarboxykinase 
J0DMD4 J0DMD4_LOALO Pseudouridine synthase 
E1GL29 E1GL29_LOALO Sodium/potassium ATPase subunit beta 
E1FQ19 E1FQ19_LOALO TAG-320 protein 
Q17172 TDX2_BRUMA Thioredoxin peroxidase 2 
Q87QI7 TORA_VIBPA Trimethylamine-N-oxide reductase 
P23232 GBB_LOLFO Guanine nucleotide-binding protein subunit beta 






Table S8. Leiomodin-1 antibodies cross-react with O. volvulus antigens. Differences in 
immune reactivity of leiomodin-1 antibodies competed with BSA or Onchocerca volvulus 
whole-cell lysates to immobilized leiomodin-1. Optical density for each immune reactivity is 
provided for data from Fig 4E.  
 
Patient ID # BSA competed O. volvulus competed 
3 108.87 85.930 
14 154.48 11.280 
20 364.22 14.110 
16 319.05 201.890 
 
